| Endothelin receptor antagonists - their role in pulmonary medicine. | |
| | |
MedLine Citation:
|
PMID: 22099418 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
INTRODUCTION: Understanding of the function of endothelin-1 in the pathophysiology of endothelial disease, in particular pulmonary arterial hypertension (PAH), has paved the way for the development of endothelin-receptor antagonists (ERAs) and explains the leading role they now play in the treatment armamentarium for this disease. BACKGROUND: Three active ERA drugs (bosentan, sitaxentan, ambrisentan) are currently approved for the treatment of PAH in France. Several randomised clinical trials have demonstrated their efficacy and safety in PAH. PERSPECTIVES AND CONCLUSION: Besides its vasoconstrictor effect, endothelin-1 (ET-1) plays a pivotal role in cell proliferation and apoptosis. ERAs are innovative drugs potentially useful in some pulmonary disorders such as idiopathic pulmonary fibrosis or systemic sclerosis, even though the preliminary results published remain insufficient or controversial. CONCLUSION: ERAs play a major role in the management of pulmonary vascular disease. Other drugs, still under study, could prove useful in the treatment of infiltrating pneumonias. |
| | |
Authors:
|
S Boniface; M Reynaud-Gaubert |
Related Documents
:
|
17202648 - Pulmonary endarteritis. 11312178 - Congenital esophageal stenosis in adults: clinical and radiographic findings in seven p... 5980718 - Pulmonary artery stenosis, a frequent part of the congenital rubella syndrome. 10988218 - Recurrent hemoptysis following a systemic-to-pulmonary anastomosis in a child with a co... 21422158 - Mitral valve repair in a patient with previous percutaneous annuloplasty with a carillo... 19837528 - An evaluation of gender and racial disparity in the decision to treat surgically arteri... |
Publication Detail:
|
Type: Journal Article Date: 2011-10-27 |
Journal Detail:
|
Title: Revue des maladies respiratoires Volume: 28 ISSN: 1776-2588 ISO Abbreviation: Rev Mal Respir Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-11-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8408032 Medline TA: Rev Mal Respir Country: France |
Other Details:
|
Languages: eng Pagination: e94-e107 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011. Published by Elsevier Masson SAS. |
Affiliation:
|
Cabinet de pneumologie, 4, avenue de Delphes, 13006 Marseille, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly.
Next Document: Snapshot of Quantiferon TB gold testing in Northern Mexico.